Home/Filings/4/0001213900-22-068717
4//SEC Filing

McGovern Jr. Donald A. 4

Accession 0001213900-22-068717

CIK 0001690080other

Filed

Nov 1, 8:00 PM ET

Accepted

Nov 2, 5:00 PM ET

Size

5.1 KB

Accession

0001213900-22-068717

Insider Transaction Report

Form 4
Period: 2022-10-31
Transactions
  • Award

    Common Stock

    2022-10-31+36,042101,969 total
Footnotes (1)
  • [F1]Issued in consideration for serving on the Board of Directors, as Lead Director, Chairman of the Audit Committee, and as a Member of the Compensation Committee and of the Risk, Safety and Regulatory Committee of the Board of Directors, for the quarter ended September 30, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.

Issuer

180 Life Sciences Corp.

CIK 0001690080

Entity typeother

Related Parties

1
  • filerCIK 0001706276

Filing Metadata

Form type
4
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 5:00 PM ET
Size
5.1 KB